Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.
Dewdney, T.G., Wang, Y., Liu, Z., Sharma, S.K., Reiter, S.J., Brunzelle, J.S., Kovari, I.A., Woster, P.M., Kovari, L.C.(2013) Bioorg Med Chem 21: 7430-7434
- PubMed: 24128815 
- DOI: 10.1016/j.bmc.2013.09.045
- Primary Citation of Related Structures:  
4GYE, 4GZF - PubMed Abstract: 
Proper proteolytic processing of the HIV-1 Gag/Pol polyprotein is required for HIV infection and viral replication. This feature has made HIV-1 protease an attractive target for antiretroviral drug design for the treatment of HIV-1 infected patients. To examine the role of the P1 and P1'positions of the substrate in inhibitory efficacy of multi-drug resistant HIV-1 protease 769 (MDR 769), we performed a series of structure-function studies ...